Dopamine-Responsive Dystonia
eMedicine (Apr), Nikhar,N.K., 2006
Parkinson's Disease
Lancet 363:1783-1793, Samii,A.,et al, 2004
Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998
Comparison of Extrapyramidal Features in 31 Path Cases of Diffuse Lewy Body Disease & 34 Cases of Parkinson's
Neurol 48:376-380, Louis,E.D.,et al, 1997
Parkinsonism-Recognition and Differential Diagnosis
BMJ 310:447-452, Quinn,N., 1995
Blood-based NfL - A biomarker for differential diagnosis of parkinsonian disorder
Neurol 88:930-937,922, Hansson, O.,et al, 2017
Sniffing Out Parkinson Disease: Can Olfactory Testing Differentiate Parkinsonian Disorders?
Neurologist 13:382-385, McKinnon,J.H.,et al, 2007
Practice Parameter: Diagnosis and Prognosis of New Onset Parkinson Disease (An Evidence-Based Review)
Neurol 66:968-975, Suchowersky,O.,et al, 2006
Diffusion-weighted MRI Differentiates the Parkinson Variant of Multiple System Atrophy from PD
Neurol 58:575-580, Schocke,M.F.H.,et al, 2002
T2-weighted MRI Differentiates Multiple System Atrophy from Parkinson's Disease
Neurol 59;1265-1267, Kraft,E.,et al, 2002
Improved Accuracy of Clinical Diagnosis of Lewy Body Parkinson's Disease
Neurol 57:1497-1499, Hughes,A.J.,et al, 2001
The Evolution of Diagnosis in Early Parkinson Disease
ArchNeurol 57:369-372, Jankovic,J.,et al, 2000
Computerized Posturography Analysis of Progressive Suprnuclear Palsy
Arch Neurol 57:1464-1469, Ondo,W.,et al, 2000
Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999
Proton Magnetic Resonance Spectroscopy in Parkinson's Disease and Progressive Supranuclear Palsy
JNNP 62:239-242, Federico,F.,et al, 1997
Distinction of Idiopathic Parkinson's Dis from Multi-Syst Atrophy by Stim of Growth-Hormone Release w Clonidine
Lancet 349:1877-1881, Kimber,J.R.,et al, 1997
Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996
Some Specific Clinical Features Differentiate Multiple System Atrophy (Striatonigral Variety) from Parkinson's Disease
Arch Neurol 52:294-298, Colosimo,C.,et al, 1995
Different of Multi Syst Atrophy from Idiopathic Parkinson's Disease Using Proton MR Spectroscopy
Ann Neurol 37:204-210, Davie,C.A.,et al, 1995
Multiple System Atrophy presenting as Parkinsonism:Clinical Features and Diagnostic Criteria
JNNP 59:144-151, Albanese,A.,et al, 1995
Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995
Eye Movements in Parkinsonian Syndromes:Vidailhet
M. , et al, Neurol 35:420-42694., , 1994
Diff Diag of parkinson's Disease, Multiple Sys Atrophy, & Steele-Richardson-Olszewski Syndrome:Striatal F-Dopa PET Data
JNNP 57:278-284, Burn,D.J.,et al, 1994
Accuracy of Clinical Diagnosis of Idiopathic Parkinson's Disease:A Clinico-Pathological Study of 100 Cases
JNNP 55:181-184, Hughes,A.J.,et al, 1992
What Features Improve the Accuracy of Clinical Diagnosis in Parkinson's Disease:A Clinicopathologic Study
Neurol 42:1142-1146, Hughes,A.J.,et al, 1992
Challenge Tests to Predict the Dopaminergic Response in Untreated Parkinson's Disease
Neurol 41:1723-1725, Highes,A.J.,et al, 1991
Striatonigral Degeneration:Clinical, MRI, & Pathologic Correlation
Neurol 40:710-711, O'Brien,C.,et al, 1990